Wed, Dec 24, 2014, 8:45 PM EST - U.S. Markets closed early today

Recent

% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • stan_long@ymail.com stan_long Feb 1, 2013 2:51 PM Flag

    CYTOKINETICS’ NEW PLAN WITH AMGEN INCREASES THE DOSE OF OPTIMISM TOWARDS THE H.F. DRUG

    This new development insinuates that Amgen, which holds an exclusive, world-wide (excluding Japan) license to omecamtiv mecarbil has reasons to believe in the value of Cytokinetics heart failure drug and continues to be invested in it. If anything in past investigations had raised doubt in the safety or efficacy of omecamtiv mecarbil, Amgen would have dropped its development all together by now.

 
CYTK
5.87+0.35(+6.34%)Dec 24 12:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
CalAmp Corp.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST